Cargando…
Diagnostic utility of LunX mRNA in peripheral blood and pleural fluid in patients with primary non-small cell lung cancer
BACKGROUND: Progress in lung cancer is hampered by the lack of clinically useful diagnostic markers. The goal of this study was to provide a detailed evaluation of lung cancer tumor markers indicative of molecular abnormalities and to assess their diagnostic utility in non-small cell lung cancer (NS...
Autores principales: | Cheng, Min, Chen, Yongyan, Yu, Xiaoqing, Tian, Zhigang, Wei, Haiming |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2424066/ https://www.ncbi.nlm.nih.gov/pubmed/18513434 http://dx.doi.org/10.1186/1471-2407-8-156 |
Ejemplares similares
-
LunX-CAR T Cells as a Targeted Therapy for Non-Small Cell Lung Cancer
por: Hu, Ziming, et al.
Publicado: (2020) -
Clinical and prognostic significance of detecting CEA, EGFR, LunX, c-met and EpCAM mRNA-positive cells in the peripheral blood, tumor-draining blood and bone marrow of non-small cell lung cancer patients
por: Rehulkova, Alona, et al.
Publicado: (2023) -
Immunogenic senescence sensitizes lung cancer to LUNX-targeting therapy
por: Jiao, Defeng, et al.
Publicado: (2021) -
Superiority and clinical significance of Lunx mRNA in the diagnosis of malignant pleural effusion caused by pulmonary carcinoma
por: Tang, Ying, et al.
Publicado: (2013) -
mRNA expression of CK19, EGFR and LUNX in patients with lung cancer micrometastasis
por: ZHANG, XIANSEN, et al.
Publicado: (2014)